RESUMEN
We reported previously that non-invasive bladder cancer expresses high level of GM3 ganglioside, whereas invasive tumors have low levels. Since glycosphingolipid synthesis in Golgi is modified greatly by a macrocyclic lactone isolated from fungi, brefeldin A (BFA), we studied effects of BFA on expression of glycosphingolipids and on invasiveness of bladder cancer cell lines. Only GM3 synthesis in invasive tumors was greatly enhanced upon treatment with BFA; synthesis of other glycosphingolipids with lacto-series type 2 or globo-series structure in both invasive and non-invasive tumors was not changed. Invasiveness of bladder cancer cells was greatly decreased in association with the great increase of GM3 synthesis induced by BFA treatment. Level of sialyl-Lex expressed in invasive cell line YTS1, which provides the adhesive property of the cells to E-selectin, was unchanged upon BFA treatment. All the bladder cancer cell lines, regardless of invasiveness, highly express tetraspanin CD9. GM3 has been implicated as a co-factor of CD9 in control of tumor cell motility. Down-regulation of CD9 is associated with metastatic properties of tumor cells and survival of patients with colonic cancer. Therefore, enhanced synthesis of GM3 induced by BFA, causing decrease of invasiveness in bladder cancer, is ascribable to the capability of GM3 to interconnect integrin with CD9, in analogy to colonic cancer and perhaps many other types of cancer.
Asunto(s)
Antifúngicos/farmacología , Brefeldino A/farmacología , Gangliósido G(M3)/metabolismo , Células Tumorales Cultivadas/efectos de los fármacos , Neoplasias de la Vejiga Urinaria/patología , Anticuerpos Monoclonales/inmunología , Adhesión Celular , División Celular/efectos de los fármacos , Cromatografía en Capa Delgada , Selectina E/metabolismo , Citometría de Flujo , Glicoesfingolípidos/metabolismo , Humanos , Interleucinas/metabolismo , Invasividad Neoplásica , Oligosacáridos/metabolismo , Antígeno Sialil Lewis X , Células Tumorales Cultivadas/metabolismo , Células Tumorales Cultivadas/patología , Neoplasias de la Vejiga Urinaria/tratamiento farmacológico , Neoplasias de la Vejiga Urinaria/metabolismoRESUMEN
Previous studies indicate that expression of higher gangliosides in renal cell carcinoma (RCC) is correlated with metastatic potential, particularly in the lung. Out of five major gangliosides in RCC, three disialogangliosides (disialogalactosylgloboside, IV(3)NeuAcIII(6)NeuAcLc(4), and IV(4)GalNAcIV(3)NeuAcIII(6)NeuAcLc(4)) bind strongly to siglec7, which is expressed highly in monocytes and natural killer cells. Out of other gangliosides tested, 2-->6 sialylparagloboside, GD3, GD2, and GT1b, but not other lacto- or ganglio-series gangliosides, showed clear binding to siglec7. In view of preferential metastasis of RCC to the lung, and binding of RCC cell line TOS-1 to lung tissue sections as shown in our previous study, we examined expression of siglec7 in the lung. siglec7 is expressed highly in resident blood cells, but not in parenchymatous cells. TOS-1 cells aggregate together strongly through adhesion with peripheral blood mononuclear cells to form large clumps. This suggests the possibility that such aggregates may form embolisms of microvasculature, particularly in the lung, which initiate metastasis. Other possible roles of higher gangliosides in RCC in promoting metastasis and tumor progression are discussed.
Asunto(s)
Antígenos CD/metabolismo , Antígenos de Diferenciación Mielomonocítica/metabolismo , Carcinoma de Células Renales/metabolismo , Gangliósidos/metabolismo , Neoplasias Renales/metabolismo , Lectinas , Animales , Secuencia de Bases , Células COS , Secuencia de Carbohidratos , Cartilla de ADN , Humanos , Inmunohistoquímica , Datos de Secuencia Molecular , Especificidad por SustratoRESUMEN
Two mucin-type glycoproteins, MUC-1 and P-selectin glycoprotein ligand-1 (PSGL-1), and glycosphingolipids (GSLs), expressed in human T-cell line HUT78, were highly enriched in low-density buoyant fraction (termed "GEM"), together with CD45, Yes, Fyn, and lck(56). Enrichment of MUC-1, PSGL-1 and GSLs, together with these signal transducer molecules in low-density membrane fraction was observable when fraction was prepared from cells either in nonionic detergent Brij 58 or in hypertonic alkaline conditions (500 mM Na(2)CO(3)). On pretreatment of cells with cholesterol-binding reagent methyl beta-cyclodextrin, levels of MUC-1 and PSGL-1 together with the above signal transducers in GEM was greatly reduced, and they were translocated into high-density membrane fraction. Similar association of lck(56), Yes, Fyn, and cSrc together with MUC-1 was also found in GEM fraction of mouse T-cell lymphoma EL4 cells expressing MUC-1 through transfection of its gene. These findings indicate the presence of another glycosyl cluster ("glycocluster"), in addition to the previously well-established GSL cluster organized with signal transducer molecules in GEM fraction, and its possible functional role in T-cells.
Asunto(s)
Membrana Celular/metabolismo , Glicoproteínas de Membrana/metabolismo , Mucina-1/metabolismo , Linfocitos T/metabolismo , Familia-src Quinasas , Animales , Línea Celular , Membrana Celular/química , Membrana Celular/efectos de los fármacos , Centrifugación por Gradiente de Densidad , Ciclodextrinas/farmacología , Electroforesis en Gel de Poliacrilamida , Glicoesfingolípidos/metabolismo , Glicosilación , Humanos , Antígenos Comunes de Leucocito/análisis , Antígenos Comunes de Leucocito/metabolismo , Proteína Tirosina Quinasa p56(lck) Específica de Linfocito/análisis , Proteína Tirosina Quinasa p56(lck) Específica de Linfocito/metabolismo , Linfoma de Células T/metabolismo , Sustancias Macromoleculares , Microdominios de Membrana/efectos de los fármacos , Microdominios de Membrana/metabolismo , Ratones , Transporte de Proteínas/efectos de los fármacos , Proteínas Proto-Oncogénicas/análisis , Proteínas Proto-Oncogénicas/metabolismo , Proteínas Proto-Oncogénicas c-fyn , Proteínas Proto-Oncogénicas c-yes , Transducción de Señal/fisiología , Fracciones Subcelulares/química , Fracciones Subcelulares/efectos de los fármacos , Fracciones Subcelulares/metabolismo , Linfocitos T/química , Linfocitos T/citología , Linfocitos T/efectos de los fármacosRESUMEN
Previous studies indicate that expression of higher gangliosides in renal cell carcinoma (RCC) is correlated with metastatic potential, particularly in the lung. Out of five major gangliosides in RCC, three disialogangliosides (disialogalactosylgloboside, IV(3)NeuAcIII(6)NeuAcLc(4), and IV(4)GalNAcIV(3)NeuAcIII(6)NeuAcLc(4)) bind strongly to siglec7, which is expressed highly in monocytes and natural killer cells. Out of other gangliosides tested, 2-->6 sialylparagloboside, GD3, GD2, and GT1b, but not other lacto- or ganglio-series gangliosides, showed clear binding to siglec7. In view of preferential metastasis of RCC to the lung, and binding of RCC cell line TOS-1 to lung tissue sections as shown in our previous study, we examined expression of siglec7 in the lung. siglec7 is expressed highly in resident blood cells, but not in parenchymatous cells. TOS-1 cells aggregate together strongly through adhesion with peripheral blood mononuclear cells to form large clumps. This suggests the possibility that such aggregates may form embolisms of microvasculature, particularly in the lung, which initiate metastasis. Other possible roles of higher gangliosides in RCC in promoting metastasis and tumor progression are discussed.
Asunto(s)
Antígenos CD/metabolismo , Antígenos de Diferenciación Mielomonocítica/metabolismo , Carcinoma de Células Renales/metabolismo , Gangliósidos/metabolismo , Lectinas , Animales , Sitios de Unión , Células COS , Carcinoma de Células Renales/patología , Progresión de la Enfermedad , Gangliósidos/fisiología , Humanos , Neoplasias Renales/metabolismo , Neoplasias Renales/patología , Células Tumorales CultivadasRESUMEN
The importance of analogues of lactosyl ceramides as basic structures of many natural glycosphingolipids provided a rationale for developing an efficient synthetic route to these compounds. We report herein a novel approach to synthesize several members of this family. Glycosylation of N-diphenylmethylene-spingosine, which exists in an imine-oxazolidine tautomeric mixture, with acetobromolactose under a modified Koenigs-Knorr condition yielded lactosyl beta-(1 --> 1) sphingosine, lactosyl beta-(1 --> 3) sphingosine and dilactosyl sphingosine in good yields. A similar glycosylation could be applicable to the synthesis of other glycosphingolipids.
Asunto(s)
Psicosina/análogos & derivados , Psicosina/síntesis química , Conformación de Carbohidratos , Secuencia de Carbohidratos , Espectroscopía de Resonancia Magnética , Datos de Secuencia Molecular , Psicosina/química , Espectrometría de Masa Bombardeada por Átomos VelocesRESUMEN
Tumors expressing a high level of certain types of tumor-associated carbohydrate antigens (TACAs) exhibit greater metastasis and progression than those expressing low level of TACAs, as reflected in decreased patient survival rate. Well-documented examples of such TACAs are: (i) H/Le(y)/Le(a) in primary non-small cell lung carcinoma; (ii) sialyl-Le(x) (SLe(x)) and sialyl-Le(a) (SLe(a)) in various types of cancer; (iii) Tn and sialyl-Tn in colorectal, lung, breast, and many other cancers; (iv) GM2, GD2, and GD3 gangliosides in neuroectodermal tumors (melanoma and neuroblastoma); (v) globo-H in breast, ovarian, and prostate cancer; (vi) disialylgalactosylgloboside in renal cell carcinoma. Some glycosylations and TACAs suppress invasiveness and metastatic potential. Well-documented examples are: (i) blood group A antigen in primary lung carcinoma; (ii) bisecting beta1 --> 4GlcNAc of N-linked structure in melanoma and other cancers; (iii) galactosylgloboside (GalGb4) in seminoma. The biochemical mechanisms by which the above glycosylation changes promote or suppress tumor metastasis and invasion are mostly unknown. A few exceptional cases in which we have some knowledge are: (i) SLe(x) and SLe(a) function as E-selectin epitopes promoting tumor cell interaction with endothelial cells; (ii) some tumor cells interact through binding of TACA to specific proteins other than selectin, or to specific carbohydrate expressed on endothelial cells or other target cells (carbohydrate-carbohydrate interaction); (iii) functional modification of adhesive receptor (integrin, cadherin, CD44) by glycosylation. So far, a few successful cases of anti-cancer vaccine in clinical trials have been reported, employing TACAs whose expression enhances malignancy. Examples are STn for suppression of breast cancer, GM2 and GD3 for melanoma, and globo-H for prostate cancer. Vaccine development canbe extended using other TACAs, with the following criteria for success: (i) the antigen is expressed highly on tumor cells; (ii) high antibody production depending on two factors: (a) clustering of antigen used in vaccine; (b) choice of appropriate carrier protein or lipid; (iii) high T cell response depending on choice of appropriate carrier protein or lipid; (iv) expression of the same antigen in normal epithelial tissues (e.g., renal, intestinal, colorectal) may not pose a major obstacle, i.e., these tissues are not damaged during immune response. Idiotypic anti-carbohydrate antibodies that mimic the surface profile of carbohydrate antigens, when administered to patients, elicit anti-carbohydrate antibody response, thus providing an effect similar to that of TACAs for suppression of tumor progression. An extension of this idea is the use of peptide mimetics of TACAs, based on phage display random peptide library. Although examples are so far highly limited, use of such "mimotopes" as immunogens may overcome the weak immunogenicity of TACAs in general.
Asunto(s)
Antígenos de Carbohidratos Asociados a Tumores/metabolismo , Vacunas contra el Cáncer/aislamiento & purificación , Neoplasias/inmunología , Neoplasias/terapia , Antígenos de Carbohidratos Asociados a Tumores/química , Antígenos de Carbohidratos Asociados a Tumores/genética , Vacunas contra el Cáncer/uso terapéutico , Secuencia de Carbohidratos , Epítopos/química , Epítopos/genética , Femenino , Glicosilación , Humanos , Masculino , Datos de Secuencia Molecular , Estructura Molecular , Neoplasias/genéticaAsunto(s)
Anticuerpos Monoclonales , Glicoconjugados/química , Glicoconjugados/inmunología , Animales , Especificidad de Anticuerpos , Secuencia de Carbohidratos , Carbohidratos/química , Carbohidratos/inmunología , Epítopos/química , Humanos , Ligandos , Datos de Secuencia Molecular , Estructura Molecular , Oligosacáridos/química , Oligosacáridos/inmunología , Antígeno Sialil Lewis XRESUMEN
Renal cell carcinoma (RCC) has been characterized by high expression of three types of disialogangliosides: two based on lacto-series type 1 structure (disialosyl Lc(4), GalNAc disialosyl Lc(4)), the other based on globo-series structure (disialosyl globopentaosylceramide; disialosyl Gb5). The present study established a mAb, 5F3, directed to disialosyl Gb5. 5F3 was established after immunization with RCC cell line ACHN. The major disialoganglioside antigen isolated from ACHN cells, showing specific reactivity with 5F3, was characterized unequivocally as disialosyl Gb5 (V(3)NeuAcIV(6)NeuAcGb5) by identification of the core structure as globopentaosylceramide (Gb5) after enzymatic and acid hydrolysis, and by 2-dimensional (1)H-NMR spectroscopy. 5F3 does not react with monosialosyl Gb5 (V(3)NeuAcGb5), Gb5, or any lacto-series structures. 5F3 strongly stained 19 of 41 cases of primary RCC tissue. It reacted with proximal tubules (but not distal tubules) of kidney, microglial cells of cerebrum and cerebellum, goblet cells of stomach and intestine, smooth muscle of various organs. It did not react with parenchymatous cells of various organs, except for kidney epithelia and prostate stroma. Immunostaining of RCC tissue by mAb 5F3, in combination with staining by other antibodies directed to globo-series and lacto-series structures, has prognostic significance in defining metastatic potential of RCC.
Asunto(s)
Anticuerpos Monoclonales/inmunología , Antígenos de Neoplasias/inmunología , Carcinoma de Células Renales/química , Carcinoma de Células Renales/inmunología , Gangliósidos/análisis , Gangliósidos/inmunología , Especificidad de Anticuerpos , Carcinoma de Células Renales/diagnóstico , Carcinoma de Células Renales/patología , Línea Celular , Ensayo de Inmunoadsorción Enzimática , Citometría de Flujo , Glicoesfingolípidos/inmunología , Humanos , Inmunohistoquímica , Espectroscopía de Resonancia Magnética , Metástasis de la Neoplasia , Especificidad de Órganos , Pronóstico , Células Tumorales CultivadasRESUMEN
BACKGROUND AND OBJECTIVES: To improve the survival rate of patients with colon cancer, liver metastases must be eradicated in a clinically occult state. This study was designed to find a predictor for potential liver metastases or micrometastases in colon cancer. METHODS: Peripheral blood samples and tumor specimens were obtained from 36 patients with colon cancers. The blood samples were subjected to reverse transcriptase-polymerase chain reaction (RT-PCR) analysis, and the expression of sialylated carbohydrates was also investigated in the tumors immunohistochemically. RESULTS: A carcinoembryonic antigen (CEA)-specific signal in the blood was detected in 9 of 12 (75%) patients with liver metastasis and in 8 of 24 (33%) patients without liver metastasis, respectively (P < 0.05). The positive rates of sialyl Lewis A (sLeA) and sialyl Lewis X (sLeX) were 36.3% and 40% in tumors without liver metastasis vs. 58.3% and 100% with liver metastasis, respectively. Within a year after surgery, liver metastases became clinically evident in three of the four patients without liver metastasis who showed a CEA-positive signal in their blood preoperatively and who had tumors with a strong expression of sLeX. CONCLUSIONS: A combination of both markers may provide prognostic information for liver metastases in colon cancer.
Asunto(s)
Neoplasias del Colon/genética , Neoplasias del Colon/patología , Antígeno Lewis X/análisis , Neoplasias Hepáticas/diagnóstico , Neoplasias Hepáticas/secundario , Oligosacáridos/análisis , Regulación Neoplásica de la Expresión Génica , Humanos , Inmunohistoquímica , Valor Predictivo de las Pruebas , ARN Neoplásico/análisis , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Antígeno Sialil Lewis XAsunto(s)
Proteínas Serina-Treonina Quinasas/metabolismo , Tirosina 3-Monooxigenasa/metabolismo , Proteínas 14-3-3 , Células 3T3 , Secuencia de Aminoácidos , Animales , Células Cultivadas , Cromatografía por Intercambio Iónico/métodos , Citosol/enzimología , Fibroblastos/enzimología , Cinética , Ratones , Datos de Secuencia Molecular , Fragmentos de Péptidos/química , Fosforilación , Proteína Quinasa C-delta , Proteínas Serina-Treonina Quinasas/aislamiento & purificación , Especificidad por Sustrato , Tirosina 3-Monooxigenasa/químicaAsunto(s)
Adhesión Celular/fisiología , Ceramidas/fisiología , Endotelio Vascular/fisiología , Gangliósido G(M3)/fisiología , Glucolípidos/fisiología , Animales , Secuencia de Carbohidratos , Células Cultivadas , Ceramidas/química , Endotelio Vascular/citología , Glicoesfingolípidos/química , Glicoesfingolípidos/fisiología , Humanos , Leucemia Basofílica Aguda , Liposomas , Melanoma Experimental , Ratones , Datos de Secuencia Molecular , Ratas , Teratoma , Células Tumorales CultivadasAsunto(s)
Caveolas/química , Caveolinas/análisis , Membrana Celular/química , Gangliósido G(M3)/aislamiento & purificación , Glicoesfingolípidos/aislamiento & purificación , Lípidos de la Membrana/aislamiento & purificación , Animales , Western Blotting , Secuencia de Carbohidratos , Caveolina 1 , Fraccionamiento Celular/métodos , Cromatografía en Capa Delgada/métodos , Electroforesis en Gel de Poliacrilamida , Gangliósido G(M3)/química , Glicoesfingolípidos/química , Melanoma Experimental , Ratones , Datos de Secuencia Molecular , Células Tumorales CultivadasRESUMEN
Flow cytometric, immunochemical and molecular studies were performed on leukemic blasts from a patient with minimally differentiated erythroleukemia (AML-M6v). The blasts expressed CD36 and CD71 but not lymphoid antigens, myeloid antigens, CD41 or glycophorin A. Analysis of carbohydrate antigens showed that the blasts expressed the sialyl-Tn antigen. Immunochemistry revealed that the blasts had neuron-specific enolase (NSE). Serum sialyl-Tn and NSE levels were markedly increased. Finally, an erythroid lineage was confirmed in the presence of alpha-globin messages in the blasts. Sialyl-Tn and NSE expression in leukemic blasts may be useful to identify AML-M6v.
Asunto(s)
Antígenos de Carbohidratos Asociados a Tumores/metabolismo , Biomarcadores de Tumor/metabolismo , Leucemia Eritroblástica Aguda/metabolismo , Proteínas de Neoplasias/metabolismo , Fosfopiruvato Hidratasa/metabolismo , Antígenos CD/metabolismo , Northern Blotting , Células de la Médula Ósea/metabolismo , Células de la Médula Ósea/patología , Diferenciación Celular , Citometría de Flujo , Humanos , Leucemia Eritroblástica Aguda/patología , Masculino , Persona de Mediana EdadRESUMEN
The alpha1,3-fucosyltransferase IV (FucTIV) encoded by its gene (FUTIV) is responsible for synthesis of Le(x) (Galbeta4[Fucalpha3]GlcNAcbeta3Galbeta1,R), which causes compaction in the morula stage of the preimplantation mouse embryo, as well as alpha1,3-fucosylation at multiple internal GlcNAc of unbranched poly-N-acetyllactosamine, termed "myeloglycan," the physiological epitope of E-selectin. Since myeloglycan-type structure is also expressed in various types of human cancer and may mediate E-selectin-dependent metastasis, expression of FUTIV is oncodevelopmentally regulated. The mechanisms controlling FUTIV expression remain to be clarified. In this report, we further characterize FUTIV gene structure and define a non-TATA box-dependent transcriptional start region just upstream from the translational start. FUTIV promoter/reporter fusion constructs defined a "full-length" promoter and highly active fragments in the macrophage-derived U937 and myeloid HL60 cell lines. One highly active fragment contains a consensus binding site for the Ets-1 transcription factor (Withers, D. A., and Hakomori, S. (1997) Glycoconj. J. 14, 764). Gel shift analysis shows specific binding to this site in nuclear extracts from U937 cells. Mutation of the Ets consensus site significantly reduces FUTIV promoter activity in both cell lines. Gel supershift and dominant negative cotransfection experiments identified the Ets family member Elk-1 as one component binding and regulating the FUTIV promoter in U937 cells. The significance of FUTIV regulation by Elk-1 is discussed.
Asunto(s)
Proteínas de Unión al ADN , Fucosiltransferasas/genética , Regulación Enzimológica de la Expresión Génica/fisiología , Proteínas Proto-Oncogénicas/fisiología , Factores de Transcripción , Secuencia de Bases , Cartilla de ADN , Humanos , Datos de Secuencia Molecular , Regiones Promotoras Genéticas , Células U937 , Proteína Elk-1 con Dominio etsRESUMEN
Endogenous GM3 synthesis and full N-glycosylation in membrane receptors occurred in "4-epimerase-less" ldlD (Krieger's CHO mutant) cells cultured in Gal-containing medium, whereby components of detergent-insoluble, low-density, buoyant membrane fraction, termed "glycolipid-enriched microdomain (GEM)," varied significantly by translocation into or out of GEM. Integrins alpha3 and alpha5 were translocated into GEM in the presence of 0.5 or 0.25% Triton X-100, particularly in the absence of Gal, whereby integrins are underglycosylated and GlcCer is the major glycolipid component in GEM. Src family kinase was translocated into and enriched in GEM fractions when prepared in 0.5 or 0.25% Triton X-100 from cells grown in Gal-containing medium, whereby GM3 synthesis is induced. In contrast, caveolin is highly enriched in GEM when GM3 synthesis does not occur, and is translocated into high-density membrane fraction when GM3 synthesis occurs. The results suggest that levels of key molecules controlling cell adhesion and signaling are defined by translocation into or out of GEM, which depends on glycosylation state.
Asunto(s)
Caveolinas , Membrana Celular/química , Membrana Celular/metabolismo , Glucolípidos/análisis , Integrinas/metabolismo , Proteínas de la Membrana/metabolismo , Familia-src Quinasas/metabolismo , Animales , Antígenos CD/metabolismo , Transporte Biológico/efectos de los fármacos , Células CHO , Caveolina 1 , Cricetinae , Gangliósido G(M3)/metabolismo , Galactosa/metabolismo , Galactosa/farmacología , Eliminación de Gen , Glucosilceramidas/metabolismo , Glicosilación/efectos de los fármacos , Integrina alfa3 , Integrina alfa5 , Octoxinol/metabolismo , Octoxinol/farmacología , Proteínas Proto-Oncogénicas pp60(c-src)/metabolismo , Solubilidad , UDPglucosa 4-Epimerasa/deficiencia , UDPglucosa 4-Epimerasa/genética , UDPglucosa 4-Epimerasa/metabolismoRESUMEN
GM3 ganglioside at the surface of mouse melanoma B16 cells is clustered and organized with signal transducer molecules c-Src, Rho A, and focal adhesion kinase (FAK) to form a membrane unit separable from caveolae, which are enriched in cholesterol and caveolin but do not contain GM3 or the above three signal transducers. The GM3-enriched membrane units are involved in GM3-dependent cell adhesion coupled with activation of c-Src, Rho A, and FAK and are termed the "glycosphingolipid signaling domain" or the "glycosignaling domain" (GSD). In order to assess the essential components that display GSD function, membranes with properties similar to those of GSD were reconstituted using GM3, sphingomyelin, and c-Src, with or without other lipid components. The reconstituted membrane thus prepared displayed GM3-dependent adhesion to plates coated with Gg3 or anti-GM3 antibody, resulting in enhanced c-Src phosphorylation (c-Src phosphorylation response). This response in reconstituted membrane depends on GM3 concentration and was not observed when GM3 was absent or replaced with other gangliosides GM1 or GD1a, or with LacCer. The GM3-dependent c-Src phosphorylation response was enhanced when cholesterol and phosphatidylcholine were added. Although GM3, sphingomyelin, and c-Src are essential for GSD function, a small quantity of cholesterol and phosphatidylcholine may act as an auxiliary factor to stabilize membrane. GSD function in terms of GM3-dependent adhesion and signaling was blocked in the presence of lyso-GM3 or its analogue but not psychosine, lactosyl-sphingosine, or lyso-phosphatidylcholine. Such susceptibility of reconstituted GSD to lyso-GM3 and other lyso compounds is the same as GSD of original B16 cells. Thus, functional organization of the reconstituted membrane closely simulates that of GSD in B16 cells, which is based on clustered GM3 organized with c-Src as the essential components.
Asunto(s)
Membrana Celular/fisiología , Gangliósido G(M3)/análogos & derivados , Proteínas Proto-Oncogénicas pp60(c-src)/metabolismo , Transducción de Señal/fisiología , Animales , Secuencia de Carbohidratos , Quinasa 1 de Adhesión Focal , Proteína-Tirosina Quinasas de Adhesión Focal , Gangliósido G(M3)/síntesis química , Gangliósido G(M3)/química , Gangliósido G(M3)/metabolismo , Gangliósidos/metabolismo , Cinética , Melanoma Experimental , Lípidos de la Membrana/metabolismo , Ratones , Datos de Secuencia Molecular , Fosforilación , Proteínas Tirosina Quinasas/metabolismo , Células Tumorales Cultivadas , Proteína de Unión al GTP rhoA/metabolismoRESUMEN
We investigated the molecular mechanism by which Sph-1-P affects the FN-dependent haptotactic motility of serum-starved mouse melanoma B16/F10 cells. We found that EDG-5-induced Rho activation followed by enhanced tyrosine phosphorylation of FAK and paxillin, and beta 1-integrin activation leading to overexpression of focal adhesion sites, as well as increment of stress fiber formation, must be the molecular basis of inhibition of haptotactic cell motility by Sph-1-P.
Asunto(s)
Proteínas de Unión al GTP/metabolismo , Lisofosfolípidos , Melanoma Experimental/patología , Proteínas Tirosina Quinasas/metabolismo , Receptores de Superficie Celular/metabolismo , Receptores Acoplados a Proteínas G , Esfingosina/análogos & derivados , Células 3T3 , Animales , Secuencia de Bases , Proteínas del Citoesqueleto/metabolismo , Cartilla de ADN , Quinasa 1 de Adhesión Focal , Proteína-Tirosina Quinasas de Adhesión Focal , Melanoma Experimental/enzimología , Melanoma Experimental/metabolismo , Ratones , Paxillin , Fosfoproteínas/metabolismo , Fosforilación , ARN Mensajero/genética , ARN Mensajero/metabolismo , Receptores de Superficie Celular/genética , Receptores Lisofosfolípidos , Esfingosina/farmacología , Células Tumorales CultivadasRESUMEN
Mouse melanoma B16 cells are characterized by a high concentration of GM3 ganglioside, which has been identified as a melanoma-associated antigen and is present as a clustered microdomain organized with major signal transducers, c-Src, small G-protein (Rho A), and focal adhesion kinase (FAK), to form a "glycosphingolipid signaling domain" or "glycosignaling domain" (GSD) separable from cholesterol- and caveolin-enriched microdomain, "caveolae." Cholesterol-binding reagents, filipin and nystatin, disrupt the structure and function of caveolae, but have no effect on GSD function [Iwabuchi, K., et al. (1998) J. Biol. Chem. 273, 33766-33773]. In this study, we searched for compounds which disrupt the structure and function of GSD in B16 cells. Such compounds should have structural features analogous to those of GM3, destroy or reduce clustering of GM3 in GSD, and inhibit GM3-dependent adhesion and signaling. The simplest compound so far found with these properties is sialyl alpha2-->1 sphingosine (Sph). We describe the synthesis of this compound and its analogues, and their effects on GM3 expression pattern and GSD function, in comparison with effects of lyso-GM3 and other lyso compounds, in B16 cells. Incubation of B16 cells with 0.5-10 microM sialyl alpha2-->1 Sph or 1-5 microM lyso-GM3 reduced GM3 clustering and GM3-dependent adhesion, and inhibited adhesion-dependent cellular FAK activity. The c-Src activation response of GSD isolated from B16 cells was inhibited strongly by sialyl alpha2-->1 Sph. Substitution of the Sph amino group with a chloroacetyl or N,N-dimethyl group strongly reduced the inhibitory effect of sialyl alpha2-->1 Sph on GM3-dependent adhesion, FAK, and c-Src response. Other lyso compounds such as lyso-phosphatidylcholine, galactosyl-Sph (psychosine), and lactosyl-Sph at 0.5-10 microM did not show the same effect as sialyl alpha2-->1 Sph. Thus, adhesion coupled with signal transduction, initiated by clusters of GM3 in GSD, is blocked by sialyl alpha2-->1 Sph or lyso-GM3. Analogues with N-substitution of Sph in sialyl alpha2-->1 Sph, other lyso-phospholipids, and galactosyl- or lactosyl-Sph did not block such adhesion, coupled with activation of c-Src and FAK.
Asunto(s)
Glicoesfingolípidos/farmacología , Melanoma Experimental/metabolismo , Transducción de Señal/efectos de los fármacos , Esfingosina/farmacología , Animales , Proteína Tirosina Quinasa CSK , Secuencia de Carbohidratos , Adhesión Celular/efectos de los fármacos , Moléculas de Adhesión Celular/metabolismo , Membrana Celular/efectos de los fármacos , Membrana Celular/enzimología , Membrana Celular/metabolismo , Activación Enzimática/efectos de los fármacos , Quinasa 1 de Adhesión Focal , Proteína-Tirosina Quinasas de Adhesión Focal , Gangliósido G(M3)/fisiología , Glicoesfingolípidos/síntesis química , Glicoesfingolípidos/química , Melanoma Experimental/enzimología , Melanoma Experimental/patología , Ratones , Datos de Secuencia Molecular , Fosforilación/efectos de los fármacos , Estructura Terciaria de Proteína/efectos de los fármacos , Proteínas Tirosina Quinasas/metabolismo , Esfingosina/análogos & derivados , Esfingosina/síntesis química , Esfingosina/química , Relación Estructura-Actividad , Células Tumorales Cultivadas , Familia-src QuinasasRESUMEN
Disialylgalactosylgloboside (DSGG), defined by monoclonal antibody RM2, is a renal cell carcinoma (RCC)-associated antigen which mediates adhesion of RCC TOS-1 cells to certain lung tissue target cells. This adhesion process may initiate preferential lung metastasis of RCC. Ganglioside GM3 is a B16 melanoma-associated antigen which similarly adheres to target cells and promotes consequent metastasis. In view of the close association of GM3-enriched microdomain with transducer molecules c-Src, Rho A, and FAK in B16 cells, we investigated the organizational status of DSGG in RCC cell line TOS-1, with the following results: i) DSGG, but not monosialylgalactosylgloboside, showed extensive clustering at the TOS-1 cell surface; ii) a low-density membrane fraction isolated from TOS-1 cells contained >95% of cellular DSGG, although protein content in this fraction was <1% of total cellular protein; iii) this fraction contained c-Src, Rho A, and FAK, but not H-Ras; iv) c-Src and Rho A were co-immunoprecipitated with DSGG through anti-DSGG mAb RM2 (IgM) affixed to a column. These observations indicate that DSGG is clustered in RCC, as typified by TOS-1 cells, to form a microdomain in which it is closely associated with c-Src, Rho A, and FAK, and may constitute a functional unit as has been observed for GM3 with transducer molecules in B16 cells. The functional organization of such units may be essential in determining malignant properties of RCC cells.
Asunto(s)
Carcinoma de Células Renales/inmunología , Gangliósidos/análisis , Neoplasias Renales/inmunología , Proteínas Proto-Oncogénicas pp60(c-src)/análisis , Proteína de Unión al GTP rhoA/análisis , Membrana Celular/química , HumanosRESUMEN
Cell adhesion and spreading on solid phase fibronectin (FN), coated on plate or presented in extracellular matrix, are mediated by integrin receptors alpha5beta1, alpha4beta1, etc., although binding of "soluble-form FN" to cell surface varies extensively depending on glycosylation status of FN per se. Deposition or incorporation at the cell surface or pericellular matrix of soluble-form FN from body fluids or synthesized de novo takes place through a yet-unknown (perhaps integrin-independent) mechanism. Here we present evidence that the mechanism involves carbohydrate-to-carbohydrate interaction. Binding or incorporation of soluble-form placental or hepatoma FN to cell surface or pericellular matrix is highly dependent on the specific glycosylation status of FN per se and combination with glycosylation status of the cell surface, and is greatly promoted by a certain type of coexisting (shedded) glycosphingolipid. A few lines of study indicate that the process is mediated by interaction of FN carbohydrate with cell surface carbohydrate. The great enhancement of the binding process by glycosphingolipid is based on dual interaction of glycosphingolipid carbohydrate with FN carbohydrate and with cell surface carbohydrate. Here we present an example of promotion of binding of soluble-form FN from placenta or from hepatoma cells, having a specific carbohydrate epitope termed "disialyl-I," to K562 or VA13 cell surface in the presence of glycosphingolipid Gg3, which interacts specifically with disialyl-I.